Cheryl A. Sherman‐Baust

2.5k total citations
16 papers, 1.9k citations indexed

About

Cheryl A. Sherman‐Baust is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Cheryl A. Sherman‐Baust has authored 16 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Cheryl A. Sherman‐Baust's work include MicroRNA in disease regulation (4 papers), Immune Cell Function and Interaction (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Cheryl A. Sherman‐Baust is often cited by papers focused on MicroRNA in disease regulation (4 papers), Immune Cell Function and Interaction (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Cheryl A. Sherman‐Baust collaborates with scholars based in United States, Japan and Russia. Cheryl A. Sherman‐Baust's co-authors include Patrice J. Morin, Ellen S. Pizer, Kathleen R. Cho, Letícia Batista Azevedo Rangel, Kevin G. Becker, Donald R. Schwartz, Colleen D. Hough, William H. Wood, F.J. Montz and Dwight D. Im and has published in prestigious journals such as Nature Communications, Nature Immunology and PLoS ONE.

In The Last Decade

Cheryl A. Sherman‐Baust

16 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl A. Sherman‐Baust United States 15 1.2k 701 417 273 263 16 1.9k
Gregory J. Riggins United States 21 1.0k 0.9× 326 0.5× 432 1.0× 116 0.4× 136 0.5× 35 1.9k
Sara Ricardo Portugal 22 879 0.7× 487 0.7× 874 2.1× 219 0.8× 80 0.3× 54 1.7k
Punit Saraon Canada 19 805 0.7× 267 0.4× 236 0.6× 152 0.6× 177 0.7× 25 1.5k
D. Stavrou Germany 24 1.2k 1.0× 472 0.7× 243 0.6× 249 0.9× 35 0.1× 90 2.3k
Leticia Oliveira‐Ferrer Germany 25 1.4k 1.2× 645 0.9× 712 1.7× 458 1.7× 86 0.3× 76 2.3k
Aya Kobayashi Japan 18 1.3k 1.1× 536 0.8× 1.2k 3.0× 391 1.4× 106 0.4× 46 2.5k
Sara A. Byron United States 18 1.3k 1.1× 549 0.8× 375 0.9× 111 0.4× 119 0.5× 48 1.9k
Sanaz Memarzadeh United States 23 1.1k 0.9× 424 0.6× 918 2.2× 345 1.3× 509 1.9× 60 2.3k
Andrea Barchetti United States 9 1.3k 1.1× 1.1k 1.6× 699 1.7× 704 2.6× 59 0.2× 12 2.7k

Countries citing papers authored by Cheryl A. Sherman‐Baust

Since Specialization
Citations

This map shows the geographic impact of Cheryl A. Sherman‐Baust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl A. Sherman‐Baust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl A. Sherman‐Baust more than expected).

Fields of papers citing papers by Cheryl A. Sherman‐Baust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl A. Sherman‐Baust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl A. Sherman‐Baust. The network helps show where Cheryl A. Sherman‐Baust may publish in the future.

Co-authorship network of co-authors of Cheryl A. Sherman‐Baust

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl A. Sherman‐Baust. A scholar is included among the top collaborators of Cheryl A. Sherman‐Baust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl A. Sherman‐Baust. Cheryl A. Sherman‐Baust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ma, Fei, Cheryl A. Sherman‐Baust, Laura B. Chopp, et al.. (2024). TCF1 dosage determines cell fate during T cell development. Science Advances. 10(48). eado5982–eado5982. 1 indexed citations
2.
Sherman‐Baust, Cheryl A., Amit Singh, Mary Kaileh, et al.. (2023). NF-κB subunits direct kinetically distinct transcriptional cascades in antigen receptor-activated B cells. Nature Immunology. 24(9). 1552–1564. 14 indexed citations
3.
Gómez-Bañuelos, Eduardo, Yikai Yu, Jessica Li, et al.. (2023). Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus. Nature Communications. 14(1). 1388–1388. 15 indexed citations
4.
Chia, Chee W., Cheryl A. Sherman‐Baust, Sara A. Larson, et al.. (2021). Age‐associated expression of p21and p53 during human wound healing. Aging Cell. 20(5). e13354–e13354. 21 indexed citations
5.
Bodogai, Monica, Kanako Moritoh, Catalina Lee-Chang, et al.. (2015). Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells. Cancer Research. 75(17). 3456–3465. 122 indexed citations
6.
Sherman‐Baust, Cheryl A., Elisabetta Kuhn, Blanca L. Valle, et al.. (2014). A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high‐grade serous carcinoma development. The Journal of Pathology. 233(3). 228–237. 96 indexed citations
7.
Sherman‐Baust, Cheryl A., Kevin G. Becker, William H. Wood, Yongqing Zhang, & Patrice J. Morin. (2011). Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. Journal of Ovarian Research. 4(1). 21–21. 72 indexed citations
8.
Li, Jianghong, et al.. (2009). Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer. 9(1). 244–244. 195 indexed citations
9.
D’Souza, Theresa, Cheryl A. Sherman‐Baust, Suresh Poosala, James M. Mullin, & Peter J. Morin. (2009). Age-Related Changes of Claudin Expression in Mouse Liver, Kidney, and Pancreas. The Journals of Gerontology Series A. 64A(11). 1146–1153. 40 indexed citations
10.
Dahiya, Neetu, Cheryl A. Sherman‐Baust, Tian‐Li Wang, et al.. (2008). MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer. PLoS ONE. 3(6). e2436–e2436. 294 indexed citations
11.
Rangel, Letícia Batista Azevedo, Rachana Agarwal, Cheryl A. Sherman‐Baust, et al.. (2004). Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers. Cancer Biology & Therapy. 3(10). 1021–1027. 138 indexed citations
12.
Rangel, Letícia Batista Azevedo, Cheryl A. Sherman‐Baust, Roman Wernyj, et al.. (2003). Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene. 22(46). 7225–7232. 117 indexed citations
13.
Sherman‐Baust, Cheryl A., Ashani T. Weeraratna, Letícia Batista Azevedo Rangel, et al.. (2003). Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell. 3(4). 377–386. 260 indexed citations
14.
Sherman‐Baust, Cheryl A., et al.. (2002). Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.. PubMed. 62(10). 2923–8. 82 indexed citations
15.
Hough, Colleen D., Cheryl A. Sherman‐Baust, Ellen S. Pizer, et al.. (2000). Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.. PubMed. 60(22). 6281–7. 410 indexed citations
16.
Hough, Colleen D., et al.. (1999). Evidence for the Colonic Origin of Ovarian Cancer Cell Line SW626. JNCI Journal of the National Cancer Institute. 91(15). 1327–1328. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory J. Riggins Breakdown of academic impact, for papers by Sara Ricardo Breakdown of academic impact, for papers by Punit Saraon Breakdown of academic impact, for papers by D. Stavrou Breakdown of academic impact, for papers by Leticia Oliveira‐Ferrer Breakdown of academic impact, for papers by Aya Kobayashi Breakdown of academic impact, for papers by Sara A. Byron Breakdown of academic impact, for papers by Sanaz Memarzadeh Breakdown of academic impact, for papers by Andrea Barchetti
Rankless by CCL
2026